Given that baseline RNase L levels have been reported to influence apoptosis sensitivity [32], we assessed its expression across our panel and found that ER + breast cancer cells expressed higher levels compared to all other tested cell lines (Fig. 5f and Supplementary Fig. 7j). The gene discussed is ESR1; the disease is breast carcinoma.